WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027861) NOVEL PHOSPHODIESTERASE INTERACTING PROTEINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027861    International Application No.:    PCT/US1999/026860
Publication Date: 18.05.2000 International Filing Date: 12.11.1999
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY [US/US]; Suite 350 900 Welch Road Palo Alto, CA 94304 (US)
Inventors: CONTI, Marco; (US).
PAHLKE, Gudrun; (US)
Agent: FIELD, Bret, E.; Bozicevic, Field & Francis LLP Suite 200 285 Hamilton Avenue Palo Alto, CA 94301 (US)
Priority Data:
60/108,255 12.11.1998 US
Title (EN) NOVEL PHOSPHODIESTERASE INTERACTING PROTEINS
(FR) NOUVELLES PROTEINES INTERAGISSANT AVEC LES PHOSPHODIESTERASES
Abstract: front page image
(EN)Nucleic acid compositions encoding novel PDE interacting proteins, as well as the novel PDE interacting proteins themselves, are provided. Also provided are methods of producing the subject nucleic acid and protein compositions. The subject polypeptide and nucleic acid compositions find use in a variety of applications, including research, diagnostic, and therapeutic agent screening applications, as well as in treatment therapies for disease conditions associated with PDE activity, particularly inflammatory diseases.
(FR)L'invention concerne des compositions d'acide nucléique codant pour de nouvelles protéines interagissant avec les phosphodiestérases (PDE); les nouvelles protéines elles-mêmes interagissant avec les PDE; et des méthodes de production des compositions d'acide nucléique et de protéines en question. Les compositions de polypeptides et d'acide nucléique de l'invention s'avèrent utiles dans de multiples applications telles que des applications de recherche, de diagnostic et de criblage d'agents thérapeutiques, ainsi que dans des traitements thérapeutiques d'états pathologiques associés à l'activité des PDE, en particulier les maladies inflammatoires.
Designated States: AU, CA, JP.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)